Medical News

RSS

Alverix and BD partner to develop point of care infectious disease diagnostic assay systems

As consumers begin to take greater ownership of their own healthcare, there is a growing demand for accessibility to diagnostic testing. Alverix, Inc. and BD (Becton, Dickinson and Company) are on the cutting edge of this trend and today announced an agreement to produce assay systems at the point-of-care (POC) that will improve infectious disease diagnoses.

From BD (Becton, Dickinson and Company) 16 Aug 2010

Jiangbo receives Shandong FDA approval to market Felodipine SR tablets

Jiangbo Pharmaceuticals, Inc., today announced that the Company received approval from the Shandong Food and Drug Administration to start the sales of Felodipine sustained release tablets.

16 Aug 2010

KHN column: Medicaid cutbacks not the same as private insurance rescission

In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Everywhere you look, Medicaid seems to be in jeopardy.

16 Aug 2010

Indiana University installs new DeltaVision|OMX imaging system from Applied Precision

Applied Precision, along with Indiana University, are excited to announce the installation of a new DeltaVision|OMX imaging system in the Light Microscopy Imaging Center in Bloomington, Indiana.

16 Aug 2010

Weikang Bio-Technology second-quarter revenue decreases 20.5% to $10.5 million

Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced its fiscal 2010 second quarter results for period ended June 30, 2010.

16 Aug 2010

UCI Medical Affiliates third-quarter revenues increase 9.23% to $21.04 million

UCI Medical Affiliates, Inc. today announced that it had filed its Quarterly Reports on Form 10-Q for the quarter ended June 30, 2010.

16 Aug 2010

Massachusetts General Hospital implants Levacor Ventricular Assist Device

World Heart Corporation, a developer of mechanical circulatory systems, announced today that the Massachusetts General Hospital in Boston, Mass. has successfully implanted its first Levacor™ Ventricular Assist Device (VAD). Mass General is the fifth implanting site nationwide in the Levacor VAD Bridge-to-Transplant (BTT) Study. This is the eleventh implant with the Levacor VAD since the inception of the BTT study.

16 Aug 2010

Cortex second-quarter net loss decreases to $0.04 per share

Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of approximately $2,454,000, or $0.04 per share, for the quarter ended June 30, 2010, compared with a net loss applicable to common stock of approximately $2,778,000, or $0.06 per share, for the corresponding prior year period.

16 Aug 2010

ePlus Technology renews IT products and services agreement with VHA

ePlus inc. today announced that its wholly owned subsidiary, ePlus Technology, Inc., has renewed its agreement with VHA Inc., a nationwide network of not-for-profit hospitals that work together to improve clinical and economic performance. ePlus will offer IT products and services as well as leasing services for IT and medical equipment to more than 1,400 VHA member healthcare institutions and 28,000+ non-acute facilities nationwide.

16 Aug 2010

WaferGen Biosystems second-quarter revenue increases to $432,000

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today reported financial results for the three and six months ended June 30, 2010.

16 Aug 2010

Titan Pharmaceuticals second-quarter net loss increases to $1.84 million

Titan Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2010.

16 Aug 2010

Align Technology releases Invisalign G3 for greater predictability of tooth movements

Align Technology, Inc. today announced the launch of Invisalign® G3, the most significant collection of new features and innovations in the company's history. Invisalign G3 is engineered to deliver even better clinical results, with new aligner and software features that make it easier to use Invisalign with Class II and Class III patients, new SmartForce™ features designed for increased predictability of certain tooth movements, and simpler, more intuitive software to streamline treatment planning and review.

16 Aug 2010

NeoStem second-quarter revenues increase 26% to $19.4 million

NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.

16 Aug 2010

PLC Systems second-quarter total revenues decrease to $1,019,000

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three- and six month periods ended June 30, 2010.

16 Aug 2010

Bruker to acquire Veeco’s worldwide SPM and OIM instruments business for $229 million

Bruker Corporation today announces the signing of an agreement to acquire the Scanning Probe Microscopy (SPM) and Optical Industrial Metrology (OIM) instruments business from Veeco Instruments, Inc. for $229 million in cash. The transaction has been approved by the Boards of Directors of both companies and is expected to close during the fourth quarter of 2010, pending regulatory review and subject to customary closing conditions.

16 Aug 2010

AMRI selected as inaugural winner of Pfizer Route Design Innovation Award

AMRI announced today that it has been selected as the inaugural winner of the Pfizer Route Design Innovation Award, beating out 40 companies who were invited to share innovative ideas for process chemistry and large scale Active Pharmaceutical Ingredient production. Pfizer will present the company with the award at the AMRI 2010 Integrated Drug Discovery Symposium to be held in Albany NY, October 13-14. AMRI will also receive an honorarium for its win.

16 Aug 2010

Vitacost.com second-quarter net sales increase 14.1% to $54.0 million

Vitacost.com, Inc., a leading online retailer and direct marketer of health and wellness products, today reported financial results for the second quarter ended June 30, 2010.

16 Aug 2010

FDA approves Teleflex's remaining requests of certificates to foreign governments

Teleflex Incorporated today announced that it has received approval of all remaining requests of certificates to foreign governments from the FDA.

16 Aug 2010

Majority of women support single woman using IVF treatment to conceive, survey finds

A recent survey of American women aged 25-45 that gauged attitudes toward In Vitro Fertilization found that 83% of these women support a single woman using IVF to conceive if she is emotionally and financially able to care for the child.

16 Aug 2010

Cryo-Cell International engages investment bank to evaluate strategic acquisition opportunities

Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks today announced that it has engaged Morgan Joseph LLC, a full service investment bank, to evaluate strategic acquisition opportunities available to enhance value for Cryo-Cell's shareholders.

16 Aug 2010